Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Daiichi, Heptares join forces to discover GPCR pain compounds

Executive Summary

Daiichi Sankyo Co. Ltd. will collaborate with Sosei Group Corp.'s Heptares Therapeutics Ltd. on a single Heptares-discovered G protein-coupled receptor (GPCR) Daiichi selects and from which the Top Japanese Pharma company will develop small-molecule pain candidates.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Synthesis Technologies, Production Processes
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register